Streptococcal B vaccine conjugate (GlaxoSmithKline)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameStreptococcal B vaccine conjugate (GlaxoSmithKline)

Drug Alias NameGBS Trivalent Vaccine链球菌B偶联疫苗 - 葛兰素史克Group B Streptococcus vaccineTrivalent PG vaccineGBS maternal vaccine +[8]

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsStreptococcal InfectionsInfections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechiaBelgiumUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesIntercell

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsStreptococcal InfectionsInfections

Other Information

ATC CodeN/A